Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LANTHANUM CARBONATE
- Different Effects of Non-calcium Phosphate Binders on Serum Calcium
- Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis
- Healthy Combine Study
- A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP1517 and Lanthanum Carbonate Hydrate
- Optimal Anemia Treatment in End Stage Renal Disease (ERSD)
- The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE
- Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia
- Phophate Lowering Trial
- Fosrenol Post-marketing Surveillance in Japan
- The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23
- A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on
- Fosrenol and Phosphorus Balance - Lanthanum Carbonate
- Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study
- Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients
- Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate
- Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus Restriction
- Circadian Rhythm Modulation by Dietary Phosphorus in Chronic Kidney Disease
- Efficacy of Lanthanum Carbonate in Calciphylaxis
- Long-term Study in Chronic Kidney Disease (Extension From Study 14817)
- Effect of Lanthanum Carbonate in Patients Previously Treated With Calcium-based Phosphate Binder Therapy
- Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKD
- Study in Chronic Kidney Disease (CKD) Not on Dialysis
- The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease
- The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Healthy Volunteers
- Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults
- Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult Volunteers
- Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)
- Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate
- A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD
- BAY 77-1931 Long-term Extension From Phase II Study
- Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone
- Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients
- Long-term Effect of Lanthanum Carbonate on Bone
- Efficacy of Phosphate Binding in Healthy Volunteers: Chewed Versus Crushed Lanthanum Carbonate
- Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5
- Head to Head Study Against Sevelamer Hydrochloride
- Low Phosphate Diets in Patients With Early Stages of Chronic Kidney Disease
- Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease
- Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease
- Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving Dialysis
- Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease
- Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood
- A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.
Clinical trials list
click for details